Company intelligence / Profile preview
Protech Telelinks
- Ownership
- Private
- Employees
- ~314
- Development stage
- Other
Overview
Protech Telelinks manufactures and markets over 1000 pharmaceutical products, including injectables (antibiotics, antifungals, vitamins) and eye drops, deployed in domestic and export markets, with operations certified under WHO GMP and DCGI/FSSAI approvals.
- Therapeutic areas
- Infectious DiseasesMetabolic Disorders
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Protech Telelinks.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Protech Telelinks.